Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (301-310 of 333) with videos related to

Pageof 34
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2015
Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)Oscar Arrieta, Andrés F Cardona, Claudio Martín, et al.
Neuro-Oncology Practice|July 17, 2023
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patientsAndrés F Cardona, Diego Fernando Chamorro Ortiz, Alejandro Ruíz-Patiño, et al.
JCO Global Oncology|May 6, 2021
Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)Aline B Lara Gongora, Gustavo Werutsky, Denis L Jardim, et al.
Translational Lung Cancer Research|May 22, 2026
Air pollution, driver mutations, and survival in non-small cell lung cancer: insights from a high-altitude Hispanic cohortMateo Tamayo, Nicolás Duque-Clavijo, Astrid Berena Herrera-López, et al.
JCO Precision Oncology|January 7, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Cancer Treatment and Research Communications|September 26, 2025
Clinicogenomic and treatment outcomes in RET fusion-positive NSCLC: A multicenter study in Latin American Hispanic patientsOscar Arrieta, Andrés F Cardona, Nicolle Wagner-Gutiérrez, et al.
Translational Oncology|November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among HispanicsAlejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Infectious Diseases and Therapy|March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 VaccinationTimothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Pageof 34

Showing results (301-310 of 333) with videos related to

Sort By:
Pageof 34
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2015
Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)Oscar Arrieta, Andrés F Cardona, Claudio Martín, et al.
Neuro-Oncology Practice|July 17, 2023
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patientsAndrés F Cardona, Diego Fernando Chamorro Ortiz, Alejandro Ruíz-Patiño, et al.
JCO Global Oncology|May 6, 2021
Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)Aline B Lara Gongora, Gustavo Werutsky, Denis L Jardim, et al.
Translational Lung Cancer Research|May 22, 2026
Air pollution, driver mutations, and survival in non-small cell lung cancer: insights from a high-altitude Hispanic cohortMateo Tamayo, Nicolás Duque-Clavijo, Astrid Berena Herrera-López, et al.
JCO Precision Oncology|January 7, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Cancer Treatment and Research Communications|September 26, 2025
Clinicogenomic and treatment outcomes in RET fusion-positive NSCLC: A multicenter study in Latin American Hispanic patientsOscar Arrieta, Andrés F Cardona, Nicolle Wagner-Gutiérrez, et al.
Translational Oncology|November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among HispanicsAlejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Infectious Diseases and Therapy|March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 VaccinationTimothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Pageof 34